Maisa Kairalla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Maisa Kairalla has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Chebabo
Universidade Federal do Rio de Janeiro (UFRJ)
1 shared publication - Bruna de Veras
GSK, Rio de Janeiro, Brazil
1 shared publication - Cecilia Maria Roteli-Martins
Faculdade de Medicina do ABC Santo AndréSP Brazil Faculdade de Medicina do ABC, Santo André, SP, Brazil
1 shared publication - Isabella Ballalai
Federação Brasileira das Associações de Ginecologia e Obstetrícia Brazil 2-Comissão Nacional Especializada de Vacinas da Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo); Sociedade Brasileira de Imunizações (SBIm), Brazil
1 shared publication - Lessandra Michelin
Universidade de Caxias do Sul
1 shared publication - Marcelo Ferreira da Costa Gomes
FIOCRUZ
1 shared publication
Latest Publications
- Open Access
- 19 August 2024
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 20 (1) , 2388943
Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel
Respiratory syncytial virus (RSV) is an important cause of respiratory illness. While most attention is paid to childhood infection, the RSV burden in adults ≥60 y should also be considered. In Brazil, this is generally underrecognized, where greater focus is toward other respiratory pathogens. This article presents insights from a multidisciplinary panel gathered to review epidemiologic data and current diagnostic approaches to RSV in Brazil (and their limitations) and develop communication strategies to improve knowledge and awareness. National surveillance data indicate a steady increase in cases of RSV-related severe acute respiratory illness (RSV-SARI) in those aged ≥60 y in recent years, with high fatality rates (>30%). Routine RSV testing in older individuals with respiratory symptoms is relatively low. Educational activities targeted toward health-care professionals and the general public are critical to raising awareness of the importance of RSV in older individuals, particularly as protective vaccines are now available.
- 19 August 2024
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 20 (1) , 2388943
Open AccessRespiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel
Respiratory syncytial virus (RSV) is an important cause of respiratory illness. While most attention is paid to childhood infection, the RSV burden in adults ≥60 y should also be considered. In Brazil, this is generally underrecognized, where greater focus is toward other respiratory pathogens. This article presents insights from a multidisciplinary panel gathered to review epidemiologic data and current diagnostic approaches to RSV in Brazil (and their limitations) and develop communication strategies to improve knowledge and awareness. National surveillance data indicate a steady increase in cases of RSV-related severe acute respiratory illness (RSV-SARI) in those aged ≥60 y in recent years, with high fatality rates (>30%). Routine RSV testing in older individuals with respiratory symptoms is relatively low. Educational activities targeted toward health-care professionals and the general public are critical to raising awareness of the importance of RSV in older individuals, particularly as protective vaccines are now available.